Dysport®

Dysport® Injections for Wrinkles: The New Botox

What is Dysport®?

Dysport® is a simple, effective, non-surgical treatment that works by relaxing facial muscles, thereby reducing and smoothing away frown-lines and wrinkles. Dysport, like Botox Cosmetic® is a protein extracted from the bacterium Clostridium Botulinum. The Dysport® protein was initially used for the treatment of motor disorders and various kinds of involuntary muscular spasms, including cerebral palsy.

Dysport® was originally to be licensed in the United States under the brand name Reloxin. Most articles pertaining to this drug in the United States referred to it as Reloxin. The FDA mandated that the drug be branded under its original name, Dysport® (rather than Reloxin) prior to its April 2009 FDA approval.

Is Dysport® New?

NO. Dysport® has been available in Europe, Asia, and South America for over 10 years. Dysport® is manufactured by Ipsen Pharmaceuticals (FRA) and is supported by over a decade of clinical experience. Dysport® is distributed in the United States by Medicis, the manufacturers of the revolutionary Restylane dermal filler. Dysport® was developed in the United Kingdom in the early 1990s to successfully treat a number of neurological and ophthalmic conditions. It was further developed to treat a wide variety of neuromuscular disorders, for which it is licensed in over 60 countries. Since that time, with an increased understanding of the uses of Dysport, thousands of treatments have been safely and effectively performed for a variety of conditions ranging from facial wrinkles to axillary hyperhidrosis (excessive sweating under the armpits).

Is Dysport® Better Than Botox?

This topic is widely debated and heavily biased due to most comparative cosmetic studies being partially or fully funded by manufacturers of Botox (Allergan) and Dysport® (Ipsen/Medicis). Many cosmetic physicians outside the U.S. who have used Dysport® report greater longevity when compared to Botox. In most unbiased neurological studies for the treatment of movement disorders Dysport® has provided equal or greater efficacy when used in a 2.5 to 4:1 ratio to Botox. In a double-blinded randomized crossover study in cervical dystonia (the most common use of neurotoxin in the world), results showed Dysport® to be more effective than Botox with a similar safety and side effect profile when used in a 3:1 dose relationship.

Why is Injector Selection More Important Than Ever?

Studies indicate that Dysport® possibly disperses more widely than Botox Cosmetic when injected. While this is advantageous when treating broader areas of small wrinkles such as crows feet, when used to treat glabellar lines of the forehead it could lead to increased occurrence of ptosis (drooping eyelid) if injected by someone inexperienced with Dysport.

Dysport® in the News